ask="6.40"
ask_size="200"
average_daily_volume="201489"
bid="6.15"
bid_size="400"
book_value="3.24"
change="+0.20"
change_from_200_day_moving_average="-4.31"
change_from_50_day_moving_average="-0.49"
change_from_52_week_high="-11.50"
change_From_52_week_low="0.95"
change_in_percent="+3.33%"
close="6.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.50"
ebitda="-19.13M"
eps_estimate_current_year="-2.79"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-2.54"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.20"
high_52_weeks="17.70"
last_trade_date="1/10/2017"
last_trade_price="6.20"
last_trade_size="100"
last_trade_time="3:59pm"
low="5.85"
low_52_weeks="5.25"
market_capitalization="48.47M"
moving_average_200_day="10.51"
moving_average_50_day="6.69"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="6.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.01%"
percent_change_from_50_day_moving_average="-7.38%"
percent_change_from_52_week_high="-64.97%"
percent_change_from_52_week_low="+18.10%"
previous_close="6.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.85"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="1.46"
stock_exchange="NCM"
symbol="TRIL"
volume="205208"
weeks_range_52="5.25 - 17.70"
